Zhejiang Haoge Pharmaceutical

Zhejiang Haoge Pharmaceutical is a pharmaceutical company based in Tongxiang, Zhejiang, China, specializing in the development, manufacturing, and commercialization of active pharmaceutical ingredients (APIs), intermediates, and finished dosage forms. Founded in 2013 and formerly known as Hongguan Bio-Pharma, the company operates state-of-the-art GMP-compliant facilities capable of producing powders, granules, tablets, capsules, and oral solutions. Its proprietary product portfolio features anti-tumor targeted molecules and other essential therapies, including commercialized drugs such as ondansetron and sulindac. In addition to its own product pipeline, the company provides comprehensive CDMO, CMO, and MAH (Marketing Authorization Holder) services to domestic and international partners. Backed by state-owned capital and leading pharmaceutical investors, Zhejiang Haoge Pharmaceutical collaborates closely with prominent academic institutions and expert teams to deliver high-quality healthcare solutions globally.